 |
|
November 10, 2008 | |
MESSAGE FROM THE DIRECTOR–Appointment of John Sweetenham, MD as Director for Clinical Trials, Case Comprehensive Cancer CenterPlease welcome John Sweetenham, MD, Professor of Medicine, Cleveland Clinic Lerner College of Medicine, to the position of Director for Clinical Trials, Case Comprehensive Cancer Center. I have established this position after consultation with the Senior Leaders of the Cancer Center. The new position of Director for Clinical Trials reflects the need for coordination and oversight of clinical trials across institutions and throughout the regional networks of the affiliated clinical sites of the Case Comprehensive Cancer Center. John will provide this specific service to the Center through his position as Deputy Associate Director for Clinical Research and Staff Investigator, a formal position in the Core Grant for individuals who provide a special coordinating activity to the Center. John comes with considerable experience managing clinical trials at cancer centers and has the title of Associate Director for Clinical Research at Cleveland Clinic. John will oversee and coordinate many components of the Case Comprehensive Cancer Center clinical trials operations. These include the Case CCC Clinical Trials Unit (Smitha Krishnamurthi, MD, Director) and the Regulatory Office for Clinical Trials for the Case CCC affiliates. He will chair the Cancer Center's Redbook Committee, which establishes the policy and procedures for the conduct of clinical trials and manages clinical trials issues as they arise throughout the Cancer Center. The Committee brings together the Clinical Trials and Regulatory Units as well as the leadership of the Data Safety and Monitoring Committee (Brenda Cooper, MD, Chair) and the Protocol Review and Monitoring Committee (Joanna Brell, MD, Chair and David Adelstein, MD, Co-chair). John's focus will be the coordination of clinical trials activities across the Case CCC, and establishing and maintaining links to the main hospital cancer center clinical trials operations where John serves as Deputy Associate Director for Clinical Research for Taussig Cancer Institute, and Afshin Dowlati, MD serves as Deputy Associate Director for Clinical Research for the Ireland Cancer Center. John will report to me until the position of Associate Director for Clinical Research at the Case Comprehensive Cancer Center is filled. He will participate in the regular meetings of the Associate Directors for Shared Resources that includes oversight of cores, biostatistics, clinical trials and informatics. Stan Gerson, MD EBEN ALSBERG, PHD NAMED ELLISON MEDICAL FOUNDATION NEW SCHOLAR IN AGINGCongratulations to Eben Alsberg, PhD, who was recently named a 2008 Ellison Medical Foundation New Scholar in Aging by the Ellison Medical Foundation. Alsberg was one of 25 people nationally to receive this honor this year. For more information, please click here. SUSAN G. KOMEN FOR THE CURE AND ASCO PAIR FOR DIVERSITY IN ONCOLOGY INITIATIVEThe American Society of Clinical Oncology (ASCO) and Susan G. Komen for the Cure have teamed up to create a Diversity in Oncology initiative, designed to facilitate the recruitment and retention of individuals from populations underrepresented in medicine to cancer careers, with particular attention to the development of clinical practitioners and investigators. Derek Raghavan, MD, Director of the Taussig Cancer Center, and Otis Brawley, MD currently serve as Co-Chairs of the ASCO Health Disparities Advisory Group. Three programs have been formed under this initiative: Komen/ ASCO Loan Repayment Program Deadline: January 15, 2009 Komen/ ASCO Medical Student Rotation Application process will open in December 2008. Komen/ ASCO Resident Travel Award Application process will open in December 2008. NCI CANCER BULLETINFeatured Article Cancer Research Highlights Guest Update by Dr. Anna Barker |
EVENTS**All events are open to anyone interested in attending November 10Hematology/Oncology Research In Progress Seminar cancelled Pathology Research Seminar Series November 11November 12Grand Rounds CSCRM Seminar November 13Physiology & Biophysics Seminar TREC Seminar Practice-Based Research Network Seminar November 14Cancer Center Seminar Series/ Blood Club cancelled Hematology/ Oncology Fellows Taussig Cancer Institute Grand Rounds more MARK YOUR CALENDARS:UPCOMING CANCER CENTER SYMPOSIUMS**For more information on these symposiums, please contact Christine Rhoads. Family-Centered Care Head and Neck Conference Ohio Collaborative Conference on Bioinformatics (OCCBIO) Annual Breast Cancer Update: Highlights of the National Meetings Case CCC Scientific Retreat 2009 |
FUNDING OPPORTUNITY– NIH 2009 Director's Pioneer and New Innovator AwardsNIH recently released the RFA for the 2009 Director's Pioneer and New Innovator Awards. Both programs are part of the NIH Roadmap for Medical Research and support exceptionally creative scientists who take highly innovative, potentially high-impact approaches to major challenges in biomedical or behavioral research. NIH expects to make 5-10 Pioneer Awards and up to 24 New Innovator Awards in September 2009. Women and members of groups that are underrepresented in NIH research are encouraged to apply. Pioneer Awards New Innovator Awards NIH LOAN REPAYMENT PROGRAMSThe NIH Loan Repayment Programs (LRPs) allow scientific investigators to remain in the research workforce, achieve research independence, and focus their efforts on advancing the health of the nation without regard to student loan debt. Each year, some 1,600 research scientists benefit from the more than $70 million NIH invests in their careers through the LRPs. The extramural LRPs include Clinical Research, Pediatric Research, Health Disparities Research, Contraception and Infertility Research, and Clinical Research for Individuals from Disadvantaged Backgrounds. New LRP contracts are awarded for a two-year period and repay up to $35,000 of qualified educational debt annually. Participants may apply for competitive renewals, which are issued for one or two years. Undergraduate, graduate, medical school and other health professional school loans qualify for repayment. An NIH grant or other NIH funding is not required to apply for or participate in the LRPs. Applicants must possess a doctoral-level degree (except for the Contraception and Infertility Research LRP); be a U.S. citizen, national, or permanent resident; devote 20 hours or more per week to conducting qualified research funded by a university, domestic nonprofit organization, or federal, state, or local government entity; and have qualified educational loan debt equal to or exceeding 20 percent of their institutional base salary (New applicants only). Deadline: December 3 For more information, please click here. FUNDING OPPORTUNITY– American Cancer Society (ACS) Audrey Meyer Mars International Fellowships in Clinical OncologyThe purpose of the Fellowships is to provide one year of advanced training in clinical oncology at participating cancer centers in the United States to qualified physicians and dentists from other countries, particularly countries where advanced training is not readily available. Applications for training in basic cancer research will not be accepted for the award. Institutions, not prospective trainees, must submit applications for the American Cancer Society (ACS) Audrey Meyer Mars International Fellowships in Clinical Oncology. If you have someone you would like to nominate for this opportunity, please contact gillian.irwin@case.edu. Internal Deadline: November 14 For eligibility and other information, please click here. FUNDING OPPORTUNITY– Friends for an Earlier Breast Cancer TestFriends for an Earlier Breast Cancer Test, a non-profit organization dedicated to promoting awareness and education and to raising funds for research into earlier detection of breast cancer, is accepting applications for Medical Research Grants. They are interested in pilot projects that focus on new methods to improve detection of early breast cancer, and are especially interested in the development of new techniques in the areas of biological or immunologic methods of early detection. It is hoped that pilot projects will provide preliminary data that lead to applications for more substantial peer-reviewed funding. Applications are accepted from both established investigators who have funding but want to embark on a new area, as well as those less experienced. In either case, the proposal should represent a new approach to the area of interest. Funds will not be given to enhance ongoing research unless it is clear that a new line of inquiry is being explored. Both domestic and international research proposals are welcome. Deadline: December 1 For more information, please click here. |
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIESPancreatic Cancer Action Network-AACR Pilot Grants |
NIH Bulletin – Notices and Funding OpportunitiesErythropoiesis Stimulating Agents and Tumor Progression (R01) (PA-09-023) Erythropoiesis Stimulating Agents and Tumor Progression (R21) (PA-09-024) Roadmap Transformative R01 Program (R01) (RFA-RM-08-029) Pre-Application for the 2009 NIH Director's Pioneer Award Program (X02)(PAR-09-012) Pre-Application for the 2009 NIH Director's New Innovator Award Program (X02) (PAR-09-013) |
|
| Produced by: Gillian Irwin 11100 Euclid Avenue, Wearn 152 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu Janice Hassinger 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-1862 phone 216-844-7832 fax janice.hassinger@uhhospitals.org |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
| If you have trouble viewing this page, click here to view the newsletter online on our website. | |